Swiss injection pen developer Haselmeier and Boston-based Common Sensing have partnered to develop smart...
Up To Date
Latest News
The UK-based pioneer in marine biotechnologies Jellagen has closed a £3.8m funding round to boost sales of its...
Iterum Therapeutics plans to raise up to US$92m in an initial public offering on US technology stock market...
US biotech company Biogen has exercised the option of a one-off payment to Swiss developer Neurimmune. If...
Norwegian Targovax ASA has given an update of its immunononcology and pancreatic cancer clinical pipeline at...
Share
